Sara Hooker, the CEO and co-founder of Adaption Labs, speaks about how the era of adding more GPUs to larger models is over ...

For patients taking medications that don't work as expected or pharmaceutical companies struggling with clinical trial failures, MetaOmics-10T represents a new starting point.

The massive explosion of generative AI models for text and image has been unavoidable lately. As these models become increasingly capable, “foundation model” is a relatively new term being tossed ...

Many organizations implementing AI agents tend to focus too narrowly on a single decision-making model, falling into the trap of assuming a one-size-fits-all decision-making framework, one that ...

The stunning capabilities of ChatGPT, the chatbot from startup OpenAI, has triggered a surge of new interest and investment in artificial intelligence. But late last week, OpenAI’s CEO warned that the ...